

Tesamorelin
Tesamorelin research compound. Supplied as a lyophilized peptide reference material for laboratory research applications.
For laboratory research use only. Not for human or veterinary use.
- Buy 2+ for $72.74 each and save 3%
- Buy 3+ for $71.24 each and save 5%
- Buy 5+ for $67.49 each and save 10%
- Buy 10+ for $63.74 each and save 15%
Direct from manufacturer to researcher
Shipping options confirmed at checkout
For laboratory research only

NEWAdvanced Laboratory Testing
Characteristics
| Molecular Formula | C221H366N72O67S |
|---|---|
| CAS Number | 218949-48-5 |
| Molar Mass | 5135.9 g/mol |
| Amino Acid Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
| Synonyms | TH9507, Egrifta, Lipodystrophy Drug |
| Solubility | Water-soluble |
| Organoleptic Profile | White to off-white powder |
| Composition | Lyophilized powder - requires reconstitution |
How does Tesamorelin work?
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that has been the subject of extensive research in the field of endocrinology and metabolism. This peptide's primary mechanism of action involves binding to and activating the growth hormone-releasing hormone receptor (GHRHR) in the anterior pituitary gland. This activation stimulates the synthesis and pulsatile release of endogenous growth hormone (GH), which in turn promotes the production of insulin-like growth factor-1 (IGF-1) in the liver and other tissues.
Handling & Safety
Handle as a laboratory research chemical of unknown hazard. Use gloves and eye protection, avoid inhalation of the lyophilized powder, and follow standard laboratory handling procedures. Reconstitute and store according to the product label. Lyophilized material should be kept cool, dry and protected from light; reconstituted material should be held at 2-8°C and protected from light. The safety profile of Tesamorelin has not been established. This compound is supplied for laboratory research use only and is not approved for human or veterinary use.
Summary
Tesamorelin is a potent growth hormone-releasing hormone (GHRH) analog that has been extensively researched for its potential to improve metabolic health, reduce visceral adipose tissue (VAT), and enhance cognitive function in various populations. By stimulating the production and release of endogenous growth hormone (GH) from the anterior pituitary gland, tesamorelin promotes the production of insulin-like growth factor-1 (IGF-1), leading to numerous metabolic and cognitive benefits. Studies have demonstrated that tesamorelin significantly reduces VAT, improves insulin sensitivity, enhances cognitive function, increases muscle mass and strength, and promotes bone health in study subjects with HIV-associated lipodystrophy, obesity, and age-related cognitive decline. As a research peptide, tesamorelin holds promise for further investigating the complex interplay between growth hormone, metabolism, and cognitive function, potentially leading to the development of novel research approaches for various metabolic and cognitive disorders. Research context only. No human or veterinary use.
Certificate of Analysis (COA)
Resource
All products on this site are for research and development use only. Products are not for human consumption of any kind. Neither the statements nor the products offered are intended to diagnose, treat, cure, or prevent any disease.
Peptide Research Insights
From the discoveries of 1977 to the next chapter in peptide science.
Explore research insights


